G
Power Law company profile
Guardant Health
Biotech & Life Sciences · Palo Alto, United States · Founded 2012 · IPO 2018 Decacorn
Valuation
$12B
Market cap · Apr/2026
Revenue
$981M
Latest reported FY
Global footprint
Where Guardant Health has talent and traffic
AI talent share
0.4%
of workforce is AI talent
(18 of 4,475 staff)
(18 of 4,475 staff)
Core AI60.13%
Other AI120.27%
Non-AI workforce4,45799.6%
Web traffic by country
85K
monthly visits
across markets
across markets
🇺🇸 United States65.3%
🇬🇧 United Kingdom12.4%
🇨🇦 Canada2.9%
🇮🇳 India2.8%
🇸🇬 Singapore2.6%
Patent intelligence
$97M patent portfolio · 163 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$97M
0.84% of market cap · 28.1× smaller than top peer Illumina ($2.7B)
163 active patent families
Where Guardant Health innovates
BioinformaticsCellComputational biologyMolecular biologyMethylation
Below peer median on Legal, Strategic, Market, Technology
Quality vs same-sector peers
Guardant Health on the five Patsnap quality dimensions
Guardant Health in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Guardant Health concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Guardant Health and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Guardant Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.